Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Gynecology Oncology Unit, Institute Clínic of Gynecology, Obstetrics, and Neonatology, Hospital Clinic of Barcelona, Barcelona, Spain.
Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3089-3097. doi: 10.1007/s00259-023-06589-3. Epub 2024 Jan 18.
The recently introduced tethered DROP-IN gamma probe has revolutionized the way robotic radioguided surgery is performed, fully exploiting the nature of steerable robotic instruments. Given this success, the current first-in-human study investigates if the DROP-IN can also provide benefit in combination with steerable non-robotic instruments during conventional laparoscopic surgery, showing equivalence or even benefit over a traditional rigid gamma probe.
The evaluation was performed in ten patients during laparoscopic cervical (n = 4) and endometrial (n = 6) cancer sentinel lymph node (SLN) procedures. Surgical guidance was provided using the hybrid, or bi-modal, SLN tracer ICG-Tc-nanocolloid. SLN detection was compared between the traditional rigid laparoscopic gamma probe, the combination of a DROP-IN gamma probe and a steerable laparoscopic instrument (LaproFlex), and fluorescence imaging.
The gynecologists experienced an enlarged freedom of movement when using the DROP-IN + LaproFlex combination compared to the rigid laparoscopic probe, making it possible to better isolate the SLN signal from background signals. This did not translate into a change in the SLN find rate yet. In both cervical and endometrial cancer combined, the rigid probe and DROP-IN + LaproFlex combination provided an equivalent detection rate of 96%, while fluorescence provided 85%.
We have successfully demonstrated the in-human use of steerable DROP-IN radioguidance during laparoscopic cervical and endometrial cancer SLN procedures, expanding the utility beyond robotic procedures. Indicating an improved surgical experience, these findings encourage further investigation and consideration on a path towards routine clinical practice and improved patient outcome.
HCB/2021/0777 and NCT04492995; https://clinicaltrials.gov/study/NCT04492995.
最近推出的带系绳的 DROP-IN 伽马探针彻底改变了机器人引导放射性手术的方式,充分利用了可操纵机器人器械的特性。鉴于这一成功,目前的首例人体研究调查了 DROP-IN 探针是否也可以在传统腹腔镜手术中与可操纵的非机器人器械结合使用,显示出与传统刚性伽马探针相比具有等效性甚至获益。
该评估在 10 名接受腹腔镜宫颈(n=4)和子宫内膜(n=6)癌前哨淋巴结(SLN)手术的患者中进行。使用混合或双模 SLN 示踪剂 ICG-Tc-纳米胶体进行手术引导。将传统刚性腹腔镜伽马探针、带系绳的 DROP-IN 伽马探针和可操纵腹腔镜器械(LaproFlex)的组合与荧光成像进行比较,评估 SLN 的检测结果。
妇科医生在使用 DROP-IN+LaproFlex 组合时体验到更大的运动自由度,这使得能够更好地将 SLN 信号与背景信号隔离开来。但这并没有转化为 SLN 检出率的变化。在宫颈和子宫内膜癌联合组中,刚性探头和 DROP-IN+LaproFlex 组合的检出率均为 96%,而荧光法为 85%。
我们已经成功地证明了在人类中使用可操纵的 DROP-IN 放射性引导进行腹腔镜宫颈和子宫内膜癌 SLN 手术,将其应用范围扩大到机器人手术之外。这些发现表明手术体验得到了改善,鼓励进一步研究并考虑将其纳入常规临床实践和改善患者预后的途径。
HCB/2021/0777 和 NCT04492995;https://clinicaltrials.gov/study/NCT04492995。